
Oncology NEWS International
- Oncology NEWS International Vol 10 No 10
- Volume 10
- Issue 10
Medicare Plans Coverage for All Treatments of Actinic Keratoses
WASHINGTON-Medicare will soon institute a policy to cover all its beneficiaries for treatments to remove actinic keratoses, sun-induced precancerous skin lesions confined to the epidermis. The decision establishes the first national coverage policy for the disorder without restrictions based on lesion or patient characteristics.
WASHINGTONMedicare will soon institute a policy to cover all its beneficiaries for treatments to remove actinic keratoses, sun-induced precancerous skin lesions confined to the epidermis. The decision establishes the first national coverage policy for the disorder without restrictions based on lesion or patient characteristics.
Previously, some Medicare contractors had restricted coverage to specific lesion types, such as those located on specific parts of the body, or to certain patients, such as those with a history of skin cancer.
Articles in this issue
about 24 years ago
High-Dose IL-2 Is Standard in Advanced Renal Cell Cancerabout 24 years ago
RIT Safe, Effective in Elderly and Poor-Prognosis Patientsabout 24 years ago
FDA Approves Xeloda/Taxotere Combination for Advanced Breast Cancerabout 24 years ago
ODAC Recommends Approval of Radiolabeled Zevalinabout 24 years ago
Proteomics Moves From the Laboratory to Clinical Researchabout 24 years ago
Radiotherapy Not Needed in Older Lumpectomy Patients With Early Cancerabout 24 years ago
Raltitrexed + Oxaliplatin for Advanced Colorectal Cancerabout 24 years ago
Mental Fatigue Worries Chemotherapy Patientsabout 24 years ago
Patients Urged to Work With Professionals Against Fatigueabout 24 years ago
NCI Director Resigns to Head New Scientific InstituteNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.

















































































